Christal Mickle
Gründer bei ZEVRA THERAPEUTICS, INC.
Vermögen: 602 023 $ am 30.04.2024
Aktive Positionen von Christal Mickle
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Corporate Officer/Principal | 10.10.2023 | - |
| Gründer | 30.10.2006 | - | |
| Direktor/Vorstandsmitglied | 30.10.2006 | 15.04.2015 | |
| Vorstandsvorsitzender | 01.06.2023 | 10.10.2023 | |
| Geschäftsführer | 30.10.2006 | 11.01.2023 | |
| Investor Relations Kontakt | 30.10.2006 | - | |
| Public Communications Contact | 18.09.2009 | - | |
| Präsident | 01.06.2023 | 10.10.2023 | |
| Unternehmenssekretär | 30.10.2006 | - | |
| Treasurer | 30.10.2006 | - |
Karriereverlauf von Christal Mickle
Ehemalige bekannte Positionen von Christal Mickle
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Corporate Officer/Principal | 01.01.2002 | 01.01.2005 |
Ausbildung von Christal Mickle
| University of Virginia | Graduate Degree |
| Virginia Polytechnic Institute & State University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
- Börse
- Insiders
- Christal Mickle
- Erfahrung
